GlaxoSmithKline and Merck KGaA strike immunotherapy deal worth up to $4 billion

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

GlaxoSmithKline and Merck KGaA have struck an immunotherapy deal worth up to $4 billion

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionGlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree... Greed. Degli inglesi , posso anche fregarmene. Ormoni o senza , sono sempre loro.
Source: Reuters - 🏆 2. / 97 Read more »

Merck named the best pharma stock by Bank of AmericaBank of America named Merck its top pick among the many U.S. pharmaceutical stocks thanks to the growing success of its key cancer drug.
Source: CNBC - 🏆 12. / 72 Read more »

Merck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionGlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree... Greed. Degli inglesi , posso anche fregarmene. Ormoni o senza , sono sempre loro.
Source: Reuters - 🏆 2. / 97 Read more »